Zinc binds to and directly inhibits protein phosphatase 2A in vitro

Neuroscience Bulletin

Volumn 31, Issue 3, 2015, Pages 331-337

  Xiong, Yan ^a,b   Luo, Dan Ju ^b   Wang, Xiu Lian ^b   Qiu, Mei ^b   Yang, Yang ^b   Yan, Xiong ^b   Wang, Jian Zhi ^b   Ye, Qi Fa ^a,d   Liu, Rong ^b,c  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

direct inhibition; protein phosphatase 2A; zinc

Indexed keywords

AGAROSE; BETA ACTIN; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 2A; TAU PROTEIN; ZINC; PHOSPHOPROTEIN PHOSPHATASE 2;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING ASSAY; CELL LYSATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; IN VITRO STUDY; MOUSE; NEUROBLASTOMA; NONHUMAN; PROTEIN BINDING; PROTEIN CONTENT; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; METABOLISM; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; IN VITRO TECHNIQUES; MICE; OKADAIC ACID; PROTEIN PHOSPHATASE 2; ZINC;

EID: 84930276457     PISSN: 16737067     EISSN: 19958218     Source Type: Journal    
DOI: 10.1007/s12264-014-1519-z     Document Type: Article

References (29)

1. Mount C, Downton C. Alzheimer disease: progress or profit? Nat Med 2006, 12: 780–784.
2. Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, Wisniewski HM. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 1986, 261: 6084–6089.
3. Wang JZ, Liu F. Microtubule-associated protein tau in development, degeneration and protection of neurons. Prog Neurobiol 2008, 85: 148–175.
4. Gong CX, Shaikh S, Wang JZ, Zaidi T, Grundke-Iqbal I, Iqbal K. Phosphatase activity toward abnormally phosphorylated tau:decrease in Alzheimer disease brain. J Neurochem 1995, 65: 732–738.
5. Gong CX, Singh TJ, Grundke-Iqbal I, Iqbal K. Phosphoprotein phosphatase activities in Alzheimer disease brain. J Neurochem 1993, 61: 921–927.
6. Ishiguro K, Shiratsuchi A, Sato S, Omori A, Arioka M, Kobayashi S, et al. Glycogen synthase kinase 3 beta is identical to tau protein kinase I generating several epitopes of paired helical filaments. FEBS Lett 1993, 325: 167–172.
7. Liu F, Grundke-Iqbal I, Iqbal K, Gong CX. Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur J Neurosci 2005, 22: 1942–1950.
8. Lovestone S, Reynolds CH, Latimer D, Davis DR, Anderton BH, Gallo JM, et al. Alzheimer’s disease-like phosphorylation of the microtubuleassociated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr Biol 1994, 4: 1077–1086.
9. Pei JJ, Braak E, Braak H, Grundke-Iqbal I, Iqbal K, Winblad B, et al. Distribution of active glycogen synthase kinase3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J Neuropathol Exp Neurol 1999, 58: 1010–1019.
10. Wang JZ, Gong CX, Zaidi T, Grundke-Iqbal I, Iqbal K. Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase 2A and 2B. J Biol Chem 1995, 270: 4854–4860.
11. Cohen P. The structure and regulation of protein phosphatases. Annu Rev Biochem 1989, 58: 453–508.
12. Mumby MC, Walter G. Protein serine/threonine phosphatases: structure, regulation, and functions in cell growth. Physiol Rev 1993, 73: 673–699.
13. Li M, Makkinje A, Damuni Z. The myeloid leukemiaassociated protein SET is a potent inhibitor of protein phosphatase 2A. J Biol Chem 1996, 271: 11059–11062.
14. Li M, Guo H, Damuni Z. Purification and characterization of two potent heat-stable protein inhibitors of protein phosphatase 2A from bovine kidney. Biochemistry-Us 1995, 34: 1988–1996.
15. Xiong Y, Jing XP, Zhou XW, Wang XL, Yang Y, Su XY, et al. Zinc induces protein phosphatase 2A inactivation and tau hyperphosphorylation through Src dependent PP2A (tyrosine 307) phosphorylation. Neurobiol Aging 2013, 34: 745–756.
16. Haase H, Maret W. Intracellular zinc fluctuations modulate protein tyrosine phosphatase activity in insulin/insulin-like growth factor-1 signaling. Exp Cell Res 2003, 291: 289–298.
17. Donella Deana A, Mac Gowan CH, Cohen P, Marchiori F, Meyer HE, Pinna LA. An investigation of the substrate specificity of protein phosphatase 2C using synthetic peptide substrates; comparison with protein phosphatase 2A. Biochim. Biophys Acta 1990, 1051: 199–202.
18. Yuan H, Vance KM, Junge CE, Geballe MT, Snyder JP, Hepler JR, et al. The serine protease plasmin cleaves the amino-terminal domain of the NR2A subunit to relieve zinc inhibition of the N-methyl-D-aspartate receptors. J Biol Chem 2009, 284: 12862–12873.
19. Fernandez JJ, Candenas ML, Souto ML, Trujillo MM, Norte M. Okadaic acid, useful tool for studying cellular processes. Curr Med Chem 2002, 9: 229–262.
20. Goldberg J, Huang HB, Kwon YG, Greengard P, Nairn AC, Kuriyan J. Three-dimensional structure of the catalytic subunit of protein serine/threonine phosphatase-1. Nature 1995, 376: 745–753.
21. Janssens V, Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J 2001, 353: 417–439.
22. Mumby M. PP2A: unveiling a reluctant tumor suppressor. Cell 2007, 130: 21–24.
23. Goldberg Y. Protein phosp hatase 2A: who shall regulate the regulator? Biochem Pharmacol 1999, 57: 321–328.
24. Chen J, Martin BL, Brautigan DL. Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation. Science 1992, 28: 1261–1264.
25. Liu R, Zhou XW, Tanila H, Bjorkdahl C, Wang JZ, Guan ZZ, et al. Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology. J Cell Mol Med 2008, 12: 241–257.
26. King MM, Huang CY. The ca lmodulin-dependent activation and deactivation of the phosphoprotein phosphatase, calcineurin, and the effect of nucleotides, pyrophosphate, and divalent metal ions. Identification of calcineurin as a Zn and Fe metalloenzyme. J Biol Chem 1984, 259: 8847–8856.
27. Zhuo S, Dixon JE. Effects of sulfhydryl regents on the activity of lambda Ser/Thr phosphoprotein phosphatase and inhibition of the enzyme by zinc ion. Protein Eng 1997, 10: 1445–1452.
28. Wang JZ, Grundke-Iqbal I, Iqbal K. Restoration of biological activity of Alzheimer abnormally phosphorylated tau by dephosphorylation with protein phosphatase-2A, -2B and -1. Brain Res Mol Brain Res 1996, 38: 200–208.
29. 2+ di-nuclear ion centers in the active site. Comp Chem 2000, 24: 381–390.